Lupin Ltd
NSE:LUPIN

Watchlist Manager
Lupin Ltd Logo
Lupin Ltd
NSE:LUPIN
Watchlist
Price: 2 071.35 INR 1.39% Market Closed
Market Cap: 944.3B INR
Have any thoughts about
Lupin Ltd?
Write Note

Lupin Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lupin Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Lupin Ltd
NSE:LUPIN
Net Income (Common)
â‚ą22.6B
CAGR 3-Years
11%
CAGR 5-Years
26%
CAGR 10-Years
1%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income (Common)
â‚ą55.7B
CAGR 3-Years
47%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Income (Common)
â‚ą44.8B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income (Common)
â‚ą110.5B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
6%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income (Common)
â‚ą18B
CAGR 3-Years
12%
CAGR 5-Years
27%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Net Income (Common)
â‚ą19.1B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Lupin Ltd
Glance View

Market Cap
943.9B INR
Industry
Pharmaceuticals

Lupin Ltd. is a global pharmaceutical powerhouse rooted in Mumbai, India, renowned for its commitment to providing high-quality, affordable medicines across a spectrum of therapeutic areas. Founded in 1968, this rapidly growing company has carved a niche in generics, specialty pharmaceuticals, and biotechnology. With a robust portfolio that includes over 1,500 products across various disciplines, particularly in cardiovascular, CNS, and anti-infective medications, Lupin has established itself as a key player in the global healthcare ecosystem. The company's strategic focus on research and development ensures a steady pipeline of innovative solutions tailored to meet the needs of patients and healthcare providers alike, positioning Lupin as a dynamic leader in the pharmaceutical industry. Driven by a global vision, Lupin operates in over 100 countries and has earned a reputation for excellence through its extensive manufacturing capabilities and adherence to stringent quality standards. The firm’s dedication to expanding its presence in developed markets, particularly in the U.S. and Europe, underscores its ambition to enhance healthcare access worldwide. For investors, Lupin represents an opportunity characterized by solid growth potential, as it continuously invests in R&D, strengthens its market position, and adapts to the evolving landscape of global healthcare. With a commitment to sustainability and a focus on creating value for stakeholders, Lupin Ltd. not only aims to thrive financially but also to enrich the lives of millions through its innovative healthcare solutions.

LUPIN Intrinsic Value
1 418.64 INR
Overvaluation 32%
Intrinsic Value
Price

See Also

What is Lupin Ltd's Net Income (Common)?
Net Income (Common)
22.6B INR

Based on the financial report for Jun 30, 2024, Lupin Ltd's Net Income (Common) amounts to 22.6B INR.

What is Lupin Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
1%

Over the last year, the Net Income (Common) growth was 133%. The average annual Net Income (Common) growth rates for Lupin Ltd have been 11% over the past three years , 26% over the past five years , and 1% over the past ten years .

Back to Top